The human µ-opioid receptor (MOR) is the major site of action of endogenous opioids and most of the clinically used opioid analgesics. The single-nucleotide polymorphism (SNP), A118G of the MOR 1 gene (OPRM1), has been associated with altered pain perception. The aim of this study was to investigate whether this polymorphism of OPRM1 is associated with a number of pain-related behaviors during labor. In this observational retrospective population-based study, pregnant women (n = 814) were recruited at gestational week 18. A plasma sample was collected from each participant and an SNP genotyping assay was performed. No differences in sociodemographic variables or labor pain-related outcomes, such as stage of cervical dilation on arrival at the delivery unit or use of any type of second-line analgesia during spontaneous labor, were found between noncarriers and G-allele carriers of OPRM1. We conclude that there is no association between the A118G polymorphism of OPRM1 regarding pain-related behavior during labor.
RowlandsSPermezelM. Physiology of pain in labour. Baillieres Clin Obstet Gynaecol. 1998;12(3):347–362.
2.
WaldenstromUBergmanVVasellG. The complexity of labor pain: experiences of 278 women. J Psychosom Obstet Gynaecol. 1996;17(4):215–228.
3.
OertelBLotschJ. Genetic mutations that prevent pain: implications for future pain medication. Pharmacogenomics. 2008;9(2):179–194.
4.
UhlGRSoraIWangZ. The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc Natl Acad Sci USA. 1999;96(14):7752–7755.
5.
BondCLaForgeKSTianMSingle-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA. 1998;95(16):9608–9613.
6.
SiaATLimYLimECA118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology. 2008;109(3):520–526.
7.
HuangCJLiuHFSuNYAssociation between human opioid receptor genes polymorphisms and pressure pain sensitivity in females. Anaesthesia. 2008;63(12):1288–1295.
8.
FillingimRBKaplanLStaudRThe A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain. 2005;6(3):159–167.
9.
GroschSNiederbergerELotschJSkarkeCGeisslingerG. A rapid screening method for a single nucleotide polymorphism (SNP) in the human MOR gene. Br J Clin Pharmacol. 2001;52(6):711–714.
10.
OertelBGPreibischCWallenhorstTDifferential opioid action on sensory and affective cerebral pain processing. Clin Pharmacol Ther. 2008;83(4):577–588.
11.
LandauRKernCColumbMOSmileyRMBlouinJL. Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women. Pain. 2008;139(1):5–14.
12.
WongCAMcCarthyRJBlouinJLandauR. Observational study of the effect of mu-opioid receptor genetic polymorphism on intrathecal opioid labor analgesia and post-cesarean delivery analgesia. Int J Obstet Anesth. 2010;19(3):246–253.
13.
BeyerAKochTSchroderHSchulzSHolltV. Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J Neurochem. 2004;89(3):553–560.
14.
BefortKFilliolDDecaillotFMGaveriaux-RuffCHoeheMRKiefferBL. A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem. 2001;276(5):3130–3137.
15.
DaboFNybergFQinZSundstrom-PoromaaIAkerudH. Plasma levels of beta-endorphin during pregnancy and use of labor analgesia. Reprod Sci. 2010;17(8):742–747.
16.
The Swedish Council on Technology Assessment in Health Care (SBU). Reports from the Swedish Council on Technology Assessment in Health Care (SBU). Int J Technol Assess Health Care. 1999;15(2):424–436.
17.
DaboFGronbladhANybergFSundstrom-PoromaaIAkerudH. Different SNP combinations in the GCH1 gene and use of labor analgesia. Mol Pain. 2010;6:41.
18.
BanfiGSalvagnoGLLippiG. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes. Clin Chem Lab Med. 2007;45(5):565–576.
19.
GinyaHAsahinaJYoshidaMDevelopment of the handy bio-strand and its application to genotyping of OPRM1 (A118G). Anal Biochem. 2007;367(1):79–86.
20.
OertelBGKettnerMScholichKA common human mu-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. J Biol Chem. 2009;284(10):6530–6535.
21.
ZhangWChangYZKanQCAssociation of human mu-opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients. Anaesthesia. 2009;65(2):130–135.
22.
BushnellMCDuncanGHHofbauerRKHaBChenJICarrierB. Pain perception: is there a role for primary somatosensory cortex?Proc Natl Acad Sci USA. 1999;96(14):7705–7709.
23.
FerrettiADel GrattaCBabiloniCFunctional topography of the secondary somatosensory cortex for nonpainful and painful stimulation of median and tibial nerve: an fMRI study. Neuroimage. 2004;23(3):1217–1225.
24.
ChouWYYangLCLuHFAssociation of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand. 2006;50(7):787–792.
25.
LotschJStuckBHummelT. The human mu-opioid receptor gene polymorphism 118A > G decreases cortical activation in response to specific nociceptive stimulation. Behav Neurosci. 2006;120(6):1218–1224.
26.
JanickiPKSchulerGFrancisDA genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain. Anesth Analg. 2006;103(4):1011–1017.
27.
Department of Health England2011. NHS Maternity Statistics 2009-2010http://www.hesonline.nhs.uk. November 2010.
28.
SakalaCDeclercqERCorryMP. Listening to Mothers: the first national U.S. survey of women's childbearing experiences. J Obstet Gynecol Neonatal Nurs. 2002;31(6):633–634.
29.
MelzackRKinchRDobkinPLebrunMTaenzerP. Severity of labour pain: influence of physical as well as psychologic variables. Can Med Assoc J. 1984;130(5):579–584.
30.
ReadingAECoxDN. Psychosocial predictors of labor pain. Pain. 1985;22(3):309–315.
31.
Lacroix-FralishMLLedouxJBMogilJS.The Pain Genes Database: an interactive web browser of pain-related transgenic knockout studies. Pain. 2007;131(1-2):3 e1–e4.
32.
SkarkeCKirchhofAGeisslingerGLotschJ. Comprehensive mu-opioid-receptor genotyping by pyrosequencing. Clin Chem. 2004;50(3):640–644.
33.
MaxMBStewartWF. The molecular epidemiology of pain: a new discipline for drug discovery. Nat Rev Drug Discov. 2008;7(8):647–658.
